P74.5
Transitory tyrosinemia of newborn
Clinical Classification Guidelines
Medical Intelligence & Overview
Transitory tyrosinemia of the newborn is a temporary condition characterized by an elevated level of tyrosine, an amino acid, in a newborn's bloodstream. This condition usually appears shortly after birth and often resolves without long-term effects. Although it can be a sign of an underlying metabolic issue, in many cases, it is a benign and self-limiting state. Recognizing the symptoms and understanding the nature of transitory tyrosinemia help guide appropriate monitoring and management during the neonatal period.
Causes & Symptoms
Clinical Causes: Immature liver enzymes in newborns, especially preterm infants, leading to reduced breakdown of tyrosine. Transient disruptions in amino acid metabolism that resolve as the newborn's liver matures. Genetic factors affecting tyrosine metabolism, but usually not indicative of a persistent metabolic disorder. Temporary nutritional imbalances or dietary factors that affect amino acid processing.
Key Symptoms: Elevated blood tyrosine levels detected in screening tests. Possible mild feeding difficulties or poor weight gain in some infants. No specific symptoms directly attributable to tyrosinemia, as it is typically subclinical. In rare cases, signs of associated liver dysfunction such as jaundice or hepatomegaly.
Diagnostic & Treatment
Diagnosis Path: Serum amino acid analysis to confirm high tyrosine levels. Assessment of liver function tests to rule out other hepatic conditions. Monitoring of tyrosine levels over time to observe the transient nature of the condition. Genetic testing may be considered to distinguish transitory tyrosinemia from persistent tyrosinemia or other metabolic disorders.
Treatment Protocols: Regular monitoring of tyrosine levels through blood tests. Ensuring an appropriate diet tailored to the infant’s nutritional needs, avoiding excessive protein intake if necessary. Supportive care for any associated symptoms or complications, such as jaundice. Follow-up appointments to confirm resolution of elevated tyrosine levels and ensure normal growth and development.
Clinical Advice & FAQs
Billing Guidance
Is P74.5 a billable ICD-10 code?
Yes, P74.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P74.5?
Clinical documentation must specify the nature of Transitory tyrosinemia of newborn and any associated comorbidities for accurate reporting.
Cite this Clinical Reference